InsidersTradesSigma
Track the Mabwell (Shanghai) Bioscience Co., Ltd. - B stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Mabwell (Shanghai) Bioscience Co., Ltd. - B has published 3 public disclosures. Market capitalisation: €9.8bn. The latest transaction was reported on 13 May 2026 (Other). Among the most active insiders: TANG Chunshan. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Mabwell (Shanghai) Bioscience Co., Ltd. is a company focused on the development of biopharmaceutical products. It specializes in the research and commercialization of innovative treatments in the healthcare sector.